A History of Outperforming Analyst Forecasts and Beating the Odds: Universal Technical Institute Inc (UTI)

With 0.89 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.02 shares. During the session, the Education & Training Services company that operates in wider Consumer Defensive sector, reached to the highest price of $16.37 whereas the lowest price it dropped to was $15.55. The 52-week range on UTI shows that it touched its highest point at $16.32 and its lowest point at $5.63 during that stretch. It currently has a 1-year price target of $17.60. Beta for the stock currently stands at 1.21.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of UTI was up-trending over the past week, with a rise of 9.72%, but this was up by 25.90% over a month. Three-month performance surged to 68.98% while six-month performance rose 93.63%. The stock gained 125.07% in the past year, while it has gained 26.20% so far this year. A look at the trailing 12-month EPS for UTI yields 0.26 with Next year EPS estimates of 0.85. For the next quarter, that number is 0.15. This implies an EPS growth rate of 440.00% for this year and 21.79% for next year.

Float and Shares Shorts:

At present, 53.73 million UTI shares are outstanding with a float of 51.14 million shares on hand for trading. On Jan 31, 2024, short shares totaled 1.14 million, which was 2.12% higher than short shares on Dec 29, 2023. In addition to Mr. Jerome A. Grant as the firm’s CEO & Director, Mr. Troy R. Anderson serves as its Executive VP & CFO.


Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for UTI since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With UTI analysts setting a high price target of $18.00 and a low target of $17.00, the average target price over the next 12 months is $17.60. Based on these targets, UTI could surge 13.92% to reach the target high and rise by 7.59% to reach the target low. Reaching the average price target will result in a growth of 11.39% from current levels.

Summary of Insider Activity:

Insiders traded UTI stock several times over the past three months with 1 Buys and 0 Sells. In these transactions, 12,361,681 shares were bought while 0 shares were sold. The number of buy transactions has increased to 17 while that of sell transactions has risen to 3 over the past year. The total number of shares bought during that period was 12,648,177 while 9,698 shares were sold.